We are live on ! Find out more
PAHC icon

Phibro Animal Health

218 hedge funds and large institutions have $794M invested in Phibro Animal Health in 2025 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 69 increasing their positions, 79 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

104% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 24

52% more capital invested

Capital invested by funds: $521M → $794M (+$273M)

32% more call options, than puts

Call options by funds: $441K | Put options by funds: $335K

12% more funds holding

Funds holding: 194218 (+24)

3.85% less ownership

Funds ownership: 100.17%96.31% (-3.9%)

13% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 79

Holders
218
Holders Change
+24
Holders Change %
+12.37%
% of All Funds
2.86%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
49
Increased
69
Reduced
79
Closed
24
Calls
$441K
Puts
$335K
Net Calls
+$106K
Net Calls Change
+$106K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$139M -$2.15M -65,197 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$61.7M -$744K -22,536 -1%
State Street
3
State Street
Massachusetts
$36.2M -$505K -15,289 -2%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$31.8M +$2.03M +61,378 +8%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$24.2M +$17.8M +537,958 +903%
Renaissance Technologies
6
Renaissance Technologies
New York
$22.5M -$1.84M -55,600 -9%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$22.1M -$257K -7,767 -1%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$19.6M -$2.37M -71,728 -13%
N
9
Nuveen
North Carolina
$19.4M +$644K +19,505 +4%
Morgan Stanley
10
Morgan Stanley
New York
$17.6M -$1.84M -55,779 -11%
CM
11
CastleKnight Management
New York
$16.2M -$4.35M -131,562 -25%
DIA
12
Dana Investment Advisors
Wisconsin
$14.4M -$1.25M -37,794 -10%
Invesco
13
Invesco
Georgia
$13M +$1.96M +59,226 +23%
Arrowstreet Capital
14
Arrowstreet Capital
Massachusetts
$12.2M +$876K +26,539 +10%
RIM
15
Ranger Investment Management
Texas
$12.1M -$1.92M -58,060 -16%
Charles Schwab
16
Charles Schwab
California
$11M +$371K +11,235 +4%
Barclays
17
Barclays
United Kingdom
$10.9M +$2.86M +86,719 +47%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$10.8M -$58.6K -1,774 -0.7%
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
$10.3M +$2.42M +73,231 +40%
CFM
20
Capricorn Fund Managers
United Kingdom
$10.2M +$8.35M +252,928 New
JP Morgan Chase
21
JP Morgan Chase
New York
$9.63M +$7.43M +225,110 +1,731%
GC
22
Globeflex Capital
California
$9.37M +$134K +4,051 +2%
Northern Trust
23
Northern Trust
Illinois
$8.98M -$87.9K -2,661 -1%
Allspring Global Investments
24
Allspring Global Investments
North Carolina
$8.93M +$7.23M +218,894 New
CIC
25
Crawford Investment Counsel
Georgia
$8.81M -$611K -18,499 -8%

PAHC Hedge Fund Activity: Q3 2025 in Review

218 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q3 2025, worth a combined $794M — up 52% from $521M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new PAHC positions and 24 closed out — a net gain of 25 holders — while 69 added to existing stakes and 79 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $17.8M. The largest seller was ExodusPoint Capital Management, cutting an estimated $21.9M.

  • 218 institutional investors held Phibro Animal Health (PAHC) as of Q3 2025, up from 194 in Q2 2025.
  • Funds reported $794M of Phibro Animal Health stock for Q3 2025, up 52% quarter-over-quarter.
  • 49 funds opened new Phibro Animal Health positions in Q3 2025 and 24 closed out, a net change of +25 holders.
  • The largest Phibro Animal Health buyer in Q3 2025 was Fidelity Investments, an estimated $17.8M added.
  • The largest Phibro Animal Health seller in Q3 2025 was ExodusPoint Capital Management, an estimated $21.9M sold.

Based on aggregated 13F filings for Q3 2025.